Aptorum Group (APM)
Developing oncology, infectious disease, and diagnostic assets for unmet medical needs.
$8.26
At close−1.44 (−14.84%)
No recent trading data
Something off on this page? Send us feedback.
EPSReportedEstimate
Sep '23Dec '23Apr '24Dec '24Apr '25Oct '25Apr '26Jul '26
Reported−$22.20−$14.30$5.10−$5.00−$2.90−$0.62−$1.30−$0.30
Estimate−$26.00−$26.00−$27.00−$26.00−$2.70———
Surprise+14.6%+45.0%+118.9%+80.8%−7.4%———
RevenueReportedEstimate
Sep '23Dec '23Apr '24Dec '24Apr '25Oct '25Apr '26Jul '26
Reported$768.4K$431.4K——————
Estimate$800.0K$1.0M$1.3M$1.0M$1.3M———
Surprise−3.9%−56.9%——————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jul 2026 | — | −$0.30 | — |
| Apr 2026 | — | −$1.30 | — |
| Jan 2026 | — | — | — |
| Oct 2025 | — | −$0.62 | — |
| Apr 2025 | −$2.70 | −$2.90 | −7.4% |
| Dec 2024 | |||
| Apr 2024 | |||
| Dec 2023 | |||
| Apr 2023 | |||
| Sep 2023 | |||
| Sep 2022 | |||
| Apr 2022 | |||
| Dec 2021 | |||
| Apr 2021 | |||
| Sep 2021 | |||
| Sep 2020 | |||
| Apr 2020 | |||
| Sep 2019 | |||
| Apr 2019 | |||
| Dec 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jul 3, 2026 | — | −$0.30 | — | — | — | — | 0.0% |
| Apr 28, 2026 | — | −$1.30 | — | — | — | — | +1.5% |
| Jan 22, 2026 | — | — | — | — | — | — | — |
| Oct 3, 2025 | — | −$0.62 | — | — | — | — | +3.1% |
| Apr 30, 2025 | −$2.70 | −$2.90 | −7.4% | $1.3M | — | — | −2.2% |
| Dec 20, 2024 | |||||||
| Apr 30, 2024 | |||||||
| Dec 22, 2023 | |||||||
| Apr 28, 2023 | |||||||
| Sep 30, 2023 | |||||||
| Sep 30, 2022 | |||||||
| Apr 29, 2022 | |||||||
| Dec 3, 2021 | |||||||
| Apr 19, 2021 | |||||||
| Sep 15, 2021 | |||||||
| Sep 1, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Sep 9, 2019 | |||||||
| Apr 15, 2019 | |||||||
| Dec 4, 2018 |